Navigation Links
Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections

ORLANDO, Fla., April 1, 2008 /PRNewswire/ -- Valensa International introduced Crannose(TM) Extra Strength Women's Health Formula at this year's Natural Products Expo West Conference. This patent-pending supplement, manufactured using novel CIT technology, combines the historically known benefits of cranberry with D-mannose, a naturally occurring, non-caloric, simple sugar, extracted from the Larch tree. The product is available in bulk, 2-piece capsules, as a beverage pre-mix or beverage sachet formula.

According to Dr. Rudi E. Moerck, President of Valensa, there is a viable and growing market for a natural promoter of urinary tract health that can affect the conditions that lead to urinary tract infections (UTIs). "Antibiotics are the standard drug-based treatment for UTIs, but they often eliminate a woman's 'good' vaginal bacteria in the course of treating the targeted infection. This situation often leads to painful secondary fungal infections like Candida that can themselves require drug treatment. The increased use of antibiotics generally has contributed to antimicrobial resistance, a growing public health concern," he added.

Dual action targets urinary tract health

During UTIs, E. coli bacteria gain a foothold by adhering to the bladder wall and/or urethra, causing infection. Crannose(TM) Extra Strength creates an environment in the bladder that helps prevent bacteria from gaining that foothold. Supplementation with Crannose(TM) Extra Strength helps to acidify the urine, while its anti-adhesion properties naturally prevent bacteria from attaching to the urinary tract lining. It provides an ideal competitive receptor site for the bacteria, creating a "path of least resistance" for it to be excreted quickly and harmlessly.

Crannose(TM) Extra Strength is very slowly metabolized in the body, so that when ingested, it travels directly to the bloodstream from the upper GI tract, and is filtered through the kidneys to the bladder for excretion -- unchanged. Crannose(TM) Extra Strength is a safe, plant-based supplement providing a healthy alternative to cranberry juice products that contain unacceptable quantities of sugar. A daily dose of just two 625 mg capsules of Crannose(TM) Extra Strength is recommended. This dosage should be doubled when a UTI is present.

According to Dr. John Minatelli, Senior Vice President, Business Development, cranberry juice has long been regarded as a preferred aid in the healthy function of the human urinary tract. "Recent studies suggest that the anti-adhesion and antioxidant properties of cranberry juice create conditions that will limit the possibility of a UTI from occurring in the first place. Research has further documented that natural D-mannose has been shown to attach to the fibrils of E. coli even more effectively than cranberry juice," he said. "Crannose(TM) Extra Strength combines the proven efficacy of unsweetened whole cranberry with the scientifically validated effects of D-mannose. This powerful combination significantly improves the anti-adhesion effectiveness over cranberry juice alone. The Crannose(TM) Extra Strength formula greatly enhances the natural D-mannose already present in cranberry, all in one low-calorie package," he added.

For further information, contact:

Sid Hulse, Vice President, Marketing & Sales

Voice: 352-357-2004 ext. 743

Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visit

SOURCE Valensa International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study: Pine bark extract reduces ADHD symptoms in children
2. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
3. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
4. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
5. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
6. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
7. Portal vein thrombosis is common in extraportal vein obstruction
8. New study: pine bark extract boosts nitric oxide production
9. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
10. Broccoli sprout-derived extract protects against ultraviolet radiation
11. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: